Drug Type Small molecule drug |
Synonyms SHR 0410, SHR-0410 |
Target |
Action agonists |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H57N7O6 |
InChIKeyAYIXVIHRKYGICQ-LHJVHYEPSA-N |
CAS Registry2168572-99-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain, Postoperative | Phase 3 | - | 01 Jul 2022 | |
Analgesia | Phase 3 | China | 12 May 2021 | |
Uremic pruritus | Phase 1 | China | 17 May 2020 | |
Pruritus | Phase 1 | Australia | 15 Apr 2019 | |
Acute Pain | Phase 1 | Australia | 15 Apr 2018 |